Advances in Women's Health

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Emily M. Godfrey, MD, MPH A recent study presented at the 2023 ACOG Annual Clinical and Scientific Meeting examined patient perspectives on clinician communication regarding medication abortion during telemedicine versus in-clinic visits and found that patients prefer to receive abortion care via telemedicine. Learn more about the study’s design and results with Dr. Charles Turck and Dr. Emily Godfrey, Professor of Family Medicine and Obstetrics and Gynecology at the University of Washington.

Guest: Mitchell D. Creinin, MD While the use of levonorgestrel 52-mg intrauterine device (IUD) has been shown to reduce blood loss in patients with heavy menstrual bleeding, these same patients are at an increased likelihood of expelling the IUD. That’s why it’s important to set realistic expectations with patients, as Dr. Mitch Creinin from the University of California Davis Health explains.

Guest: Mitchell D. Creinin, MD Dive into the research presented at the 2023 ACOG Annual Scientific and Clinical Meeting that found that the use of levonorgestrel 52-mg intrauterine device (IUD) in patients with heavy menstrual bleeding reduced blood loss by more than 90 percent over six months with Dr. Mitch Creinin, Professor in the Department of Obstetrics and Gynecology as well as the Director of the Complex Family Planning Fellowship at the University of California Davis Health.

Guest: Tiffany A. Moore Simas, MD, MPH, MEd, FACOG According to a poster that was featured at the 2023 ACOG Annual Clinical and Scientific Meeting, only 75 percent of patients at UMass Chan Medical School were screened for perinatal mental health conditions, and of those screened, white patients were more likely to be connected with appropriate care and treatment than black or Hispanic patients. Dive deeper into the findings that underscore the importance of addressing disparities and inequities in perinatal depression care with Dr. Tiffany Moore Simas, Chair of the Department of Obstetrics and Gynecology at UMass Chan Medical School.

Guest: Tiffany A. Moore Simas, MD, MPH, MEd, FACOG Host: Charles Turck, PharmD, BCPS, BCCCP New guidelines regarding the screening, diagnosis, and pharmacological treatment of perinatal mental health conditions as well as resources like in-depth toolkits and implementation guides are now available to help optimize the management of patients with perinatal mental health conditions. Find out how these tools can help you better address one of the most common complications of pregnancy with Dr. Charles Turck and Dr. Tiffany Moore Simas, the Chair of the Department of Obstetrics and Gynecology at UMass Chan Medical School who presented a few sessions focusing on this exact topic at the 2023 ACOG Annual Clinical and Scientific Meeting.

Host: Lee P. Shulman, MD, FACMG, FACOG Guest: Roberto Romero, MD, DMedSci Renowned international expert Dr. Roberto Romero joins Dr. Lee Shulman to walk us through maternal anti-fetal rejection. Find out about its pathophysiology, mechanisms of disease, approach to diagnosis, and potential treatment so that you can broaden your understanding and improve the care you provide.

Host: Jennifer Caudle, DO Guest: Tamera A. Paczos, MD, FACOG, FACP The utility of p16 and Ki-67 immunostaining in biopsies has helped lead to the development of dual staining in cytology specimens. So what do clinicians need to know about the dual stain cytology test? Take a deep dive into this topic as Dr. Jennifer Caudle is joined by Dr. Tamera A. Paczos, Vice President, Associate Chief Medical Officer with BioReference Laboratories. COBAS and CINTEC are trademarks of Roche.All other product names and trademarks are the property of their respective owners. 02/23

Host: Lee P. Shulman, MD, FACMG, FACOG Guest: Alexandra Benachi, MD, PhD Guest: Julien Zuber, MD, PhD Program Chairman:Roberto Romero, MD, DMedSciChief, Perinatology Research BranchDivision of Maternal-Fetal Medicine and ObstetricsDivision of Intramural ResearchNICHD/NIH/DHHSEditor-in-Chief for ObstetricsThe American Journal of Obstetrics and Gynecology There exists a long-standing controversy about drawing parallels between transplant and pregnancy immunology. Listen in as Drs. Alexandra Benachi, Julien Zuber, and Lee Shulman discuss why these considerations are so important for you and your colleagues, patients, and their families to understand. Discover how links between kidney transplantation and maternal anti-fetal rejection may impact your practice and spark new pathways in medicine.

Host: Jennifer Caudle, DO Guest: Diane M. Harper, MD, MPH, MS There are several testing methods available for cervical cancer screening, such as co-testing and primary HPV testing. So what are some of the most prominent benefits and limitations of these and other testing approaches? Joining Dr. Jennifer Caudle to break down the latest advancements in cervical cancer screening is Dr. Diane Harper, a Professor in the Departments of Family Medicine and Obstetrics and Gynecology at the University of Michigan.

Host: Lee P. Shulman, MD, FACMG, FACOG Guest: Masja de Haas, MD, PhD Program Chairman:Roberto Romero, MD, DMedSciChief, Perinatology Research BranchDivision of Maternal-Fetal Medicine and ObstetricsDivision of Intramural ResearchNICHD/NIH/DHHSEditor-in-Chief for ObstetricsThe American Journal of Obstetrics and Gynecology Neonatal alloimmune neutropenia (NAIN or NIN) is a neutrophil blood group antagonism similar to HDFN and FNAIT. Its presentation varies clinically and ranges from asymptomatic to severe manifestations such as sepsis and meningitis. Listen in as Drs. Masja de Haas and Lee Shulman discuss clinical clues that should catch your eye. Discover novel yet simple ways to be vigilant and make the right clinical calls.

HPV testing plays an important role in cervical cancer screening, but not every patient who's HPV-positive will develop cervical cancer. One option that can help us identify which HPV-positive patients are truly at risk is CINtec PLUS Cytology, an immunohistochemistry test that simultaneously detects p16 and Ki67 biomarker proteins. Learn more about how this dual staining technique works in this video.

Host: Andrea Singer, MD, FACP, CCD Guest: Paul A. Anderson, MD Guest: Susan V. Bukata, MD, FAOA, FAAOS Since the recording of this CME activity, the following updates have been published: NAMS Position Statement on the Management of Osteoporosis in Postmenopausal Women Menopause. 2021;28(9):973-997. Consensus Statement from the Bone Health and Osteoporosis Foundation, formerly known as the National Osteoporosis Foundation The Clinician’s Guide to Prevention and Treatment of Osteoporosis. Osteoporosis Int. 2022;33(10):2049-2102. While there’s growing awareness among orthopedic surgeons that osteoporosis is the underlying cause of fractures, there is often a disconnect between this recognition and action in the form of treatment to prevent subsequent fractures. In this discussion, Drs. Andrea Singer, Paul Anderson, and Susan Bukata address the pathophysiology of osteoporosis and the need to identify patients at risk for additional fractures. Osteoporosis treatment (including pharmacotherapy) can play a critical role in preventing future fractures, but physicians must first recognize that fracture is a sentinel event and treat it as a call to action.

Host: Lee P. Shulman, MD, FACMG, FACOG Guest: James B. Bussel, MD Program Chairman:Roberto Romero, MD, DMedSciChief, Perinatology Research BranchDivision of Maternal-Fetal Medicine and ObstetricsDivision of Intramural ResearchNICHD/NIH/DHHSEditor-in-Chief for ObstetricsThe American Journal of Obstetrics and Gynecology As the platelet equivalent of hemolytic disease of the fetus and newborn, fetal and neonatal alloimmune thrombocytopenia (FNAIT) is an uncommon yet complex and life-threatening bleeding disorder that results from incompatibility between mother and baby for platelet-specific antigens. Despite relatively normal platelet function, in the setting of severe thrombocytopenia, intracranial hemorrhage is a consequence. Drs. Shulman and Bussel discuss advances in management strategies and concrete steps you can take to lower the risk and stop the progression of this disorder in your patients.

Host: Lee P. Shulman, MD, FACMG, FACOG Guest: Linda Bradley, MD Join Drs. Linda Bradley and Lee Shulman as they discuss factors contributing to disparities in care for patients with endometriosis and/or uterine fibroids. They offer practical tips to overcome the disproportionate disease burden that especially impacts women of color. Cut through the noise to clearly hear each patient’s voice. Your clinical impact may be profound.

Host: Lee P. Shulman, MD, FACMG, FACOG Guest: Linda Bradley, MD Join Drs. Linda Bradley and Lee Shulman as they discuss factors contributing to disparities in care for patients with endometriosis and/or uterine fibroids. They offer practical tips to overcome the disproportionate disease burden that especially impacts women of color. Cut through the noise to clearly hear each patient’s voice. Your clinical impact may be profound.

Host: Lee P. Shulman, MD, FACMG, FACOG Guest: Kenneth J. Moise Jr., MD Program Chairman: Roberto Romero M.D. D.Med Sci.Chief, Perinatology Research BranchDivision of Maternal-Fetal Medicine and ObstetricsDivision of Intramural ResearchNICHD/NIH/DHHSEditor-in-Chief for ObstetricsThe American Journal of Obstetrics and Gynecology Are you taking the right steps to consistently ensure all of your patients at risk of alloimmune disorders of pregnancy, specifically HDFN, receive a helping hand plus timely and appropriate clinical care? Despite having considerable clinical consequences, this area of medicine is not fully understood by many clinicians. Drs. Shulman and Moise provide expert insight on red blood cell alloimmunization, highlighting essential pathophysiology and current and evolving management strategies. Join us to learn new ways to approach this complicated and rare clinical condition.

Host: Lee P. Shulman, MD, FACMG, FACOG Guest: Nanette F. Santoro, MD Tune out the noise and get to the heart of managing menopause and associated vasomotor symptoms. This program provides highlights from the 2022 American College of Obstetricians and Gynecologists Annual Clinical and Scientific Meeting. Join Drs. Nanette Santoro and Lee Shulman as they dive into the latest research, which could alter your current practice patterns and help your patients cool off.

Host: Ayman Al-Hendy, MD Despite its profound impact, endometriosis remains critically undermanaged. This program provides highlights from a live symposium at the annual meeting for obstetrics and gynecology professionals and is based on patient & provider surveys. Join Dr. Ayman Al-Hendy to explore management gaps, the role of GnRH antagonists in addressing deficits, and the latest research, which he presented with Drs. Andrea Lukes and Lee Shulman—you might just alter your current practice patterns.

Host: Jeffery D. Dunn, PharmD, MBA Guest: Gary M. Owens, MD Guest: Anita L. Nelson, MD Are you ready to see what is on the horizon to more effectively navigate vasomotor symptoms (VMS)? Join Drs. Dunn, Owens, and Nelson as they discuss highlights from a symposium held at AMCP 2022 featuring the latest data on the impact of menopause and evolving treatments options. They provide guidance, context, and recommendations for the medical management of VMS beyond estrogen. The nonhormonal treatment options that are currently being studied represent a new horizon for both patients and payers.

Host: Patty Cason, RN, MS, FNP-BC Guest: Joely Pritzker, RN, MS, FNP-C Are you ready to apply the latest counseling techniques to address the contraceptive revolution? Join nurse practitioners Patty Cason and Joely Pritzker as they briefly review the history of contraceptive counseling and then use case vignettes to illustrate how shared decision-making techniques will support the appropriate use of nonhormonal contraceptive options, such as the vaginal pH modulator (VPM). Participating in...